DE3325131C2 - - Google Patents

Info

Publication number
DE3325131C2
DE3325131C2 DE3325131A DE3325131A DE3325131C2 DE 3325131 C2 DE3325131 C2 DE 3325131C2 DE 3325131 A DE3325131 A DE 3325131A DE 3325131 A DE3325131 A DE 3325131A DE 3325131 C2 DE3325131 C2 DE 3325131C2
Authority
DE
Germany
Prior art keywords
cells
interferon
ifn
human
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE3325131A
Other languages
German (de)
English (en)
Other versions
DE3325131A1 (de
Inventor
Allan P. Jun. Newburyport Mass. Us Jarvis
David I. Newton Mass. Us Kosowsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Biotech Inc
Original Assignee
Damon Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Damon Biotech Inc filed Critical Damon Biotech Inc
Publication of DE3325131A1 publication Critical patent/DE3325131A1/de
Application granted granted Critical
Publication of DE3325131C2 publication Critical patent/DE3325131C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DE19833325131 1982-07-12 1983-07-12 Interferon e und seine herstellung und pharmazeutische verwendung Granted DE3325131A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39761082A 1982-07-12 1982-07-12

Publications (2)

Publication Number Publication Date
DE3325131A1 DE3325131A1 (de) 1984-01-12
DE3325131C2 true DE3325131C2 (US07754267-20100713-C00017.png) 1987-08-13

Family

ID=23571912

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19833325131 Granted DE3325131A1 (de) 1982-07-12 1983-07-12 Interferon e und seine herstellung und pharmazeutische verwendung

Country Status (12)

Country Link
AU (1) AU573528B2 (US07754267-20100713-C00017.png)
BE (1) BE897263A (US07754267-20100713-C00017.png)
CH (1) CH664575A5 (US07754267-20100713-C00017.png)
DE (1) DE3325131A1 (US07754267-20100713-C00017.png)
DK (1) DK319883A (US07754267-20100713-C00017.png)
FR (1) FR2531865A1 (US07754267-20100713-C00017.png)
GB (1) GB2123835B (US07754267-20100713-C00017.png)
IL (1) IL69205A0 (US07754267-20100713-C00017.png)
IT (1) IT1203677B (US07754267-20100713-C00017.png)
NL (1) NL8302484A (US07754267-20100713-C00017.png)
NO (1) NO832517L (US07754267-20100713-C00017.png)
SE (1) SE8303925L (US07754267-20100713-C00017.png)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3515803A1 (de) * 1984-07-06 1986-01-16 Damon Biotech, Inc., Needham Heights, Mass. Verfahren zur bestimmung von interferon-(epsilon)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4614651A (en) * 1981-07-12 1986-09-30 Damon Biotech, Inc. Interferon epsilon
NL8401911A (nl) * 1984-06-15 1986-01-02 Stichting Rega V Z W Antiviraal proteine, werkwijze voor het produceren daarvan, en farmaceutische preparaten die dit proteine bevatten.
CA2311681A1 (en) 1997-12-08 1999-06-17 Genentech, Inc. Human interferon-epsilon: a type i interferon
ZA9811070B (en) 1997-12-08 2000-07-03 Genentech Inc Type I interferons.
IL142061A0 (en) * 1998-09-18 2002-03-10 Zymogenetics Inc Interferon-epsilon
AU3107000A (en) * 1998-12-01 2000-06-19 Genentech Inc. Methods and compositions for inhibiting neoplastic cell growth
CN111420033A (zh) * 2020-03-30 2020-07-17 温州肯恩大学(Wenzhou-KeanUniversity) 人干扰素 -ε在肿瘤治疗中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237224A (en) * 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
US4016036A (en) * 1975-11-14 1977-04-05 Massachusetts Institute Of Technology Process for serially culturing keratinocytes
EP0014050A3 (en) * 1979-01-16 1980-10-01 Beecham Group Plc Interferon production
JPS56135420A (en) * 1980-03-26 1981-10-22 Fumiaki Taguchi Suppressive substance of virus and its preparation
JPS56167624A (en) * 1980-05-29 1981-12-23 Toray Ind Inc Method of interferon production

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3515803A1 (de) * 1984-07-06 1986-01-16 Damon Biotech, Inc., Needham Heights, Mass. Verfahren zur bestimmung von interferon-(epsilon)

Also Published As

Publication number Publication date
GB8318726D0 (en) 1983-08-10
AU573528B2 (en) 1988-06-16
SE8303925L (sv) 1984-01-13
SE8303925D0 (sv) 1983-07-11
DE3325131A1 (de) 1984-01-12
IT1203677B (it) 1989-02-15
NO832517L (no) 1984-01-13
IT8367757A0 (it) 1983-07-12
BE897263A (fr) 1983-11-03
IL69205A0 (en) 1983-11-30
DK319883D0 (da) 1983-07-11
GB2123835B (en) 1986-06-18
GB2123835A (en) 1984-02-08
NL8302484A (nl) 1984-02-01
FR2531865A1 (fr) 1984-02-24
DK319883A (da) 1984-01-13
AU1674883A (en) 1984-01-19
CH664575A5 (de) 1988-03-15

Similar Documents

Publication Publication Date Title
DE3001585C2 (de) Verfahren zur Herstellung von Interferon Typ I und II
DE3227262C3 (de) Verfahren zur Herstellung von menschlichem Tumor-Nekrose-Faktor und menschlicher Tumor-Nekrose-Faktor
DE3689246T2 (de) Physiologisch aktives Polypeptid BUF-3.
DE2902136C2 (de) Verfahren zum Herstellen von Interferon
DE3520228C2 (de) Wasserlösliche bioaktive Trockenfeststoffzusammensetzung, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
DE3688841T2 (de) Schwache interferondosierung für die erhöhung der impfstoffwirksamkeit.
CH684892A5 (de) DNA, welche für ein Polypeptid mit der Aktivität von menschlichem Interferon und beta 2 kodiert und Verfahren zu dessen Herstellung.
DE3027105A1 (de) Verfahren zur herstellung eines die proliferation und differenzierung menschlicher granulopoetischer stammzellen stimulierenden faktors
WO1989007946A1 (en) Virally modified tumour vaccines for immunotherapy of tumour metastases
DE3650032T2 (de) Anticytomegaloviraler menschlicher monoklonaler antikörper und dessen herstellung.
DE2628914C2 (US07754267-20100713-C00017.png)
DE3019847C2 (de) Verfahren zur Herstellung von Humaninterferon
DE3325131C2 (US07754267-20100713-C00017.png)
CH666050A5 (de) Verfahren zur herstellung von interferon epsilon.
EP1124575A1 (de) Verfahren zur herstellung eines antiviralen mittels
DE69024693T2 (de) Gene, die ein Protein mit menschlicher MACIF-Aktivität kodieren, Expressionsvektoren mit diesen Genen, Transformantenzellen und Proteine mit menschlicher MACIF-Aktivität
DE2930604A1 (de) Doppelstrangige ribonucleinsaeure, verfahren zu ihrer herstellung und diese enthaltende interferon-induktoren
DE3752184T2 (de) Herstellung und Verwendungen von gamma-Interferon
EP0203382A2 (de) Verfahren zur Herstellung und Reinigung von alpha-Interferon
EP1059931B1 (de) Verwendung von cd137 zur förderung der proliferation peripherer monocyten
DE3539775A1 (de) Neues lymphokin, gegen dieses lymphokin spezifische antikoerper, verfahren zu ihrer herstellung und ihre verwendung
DE3877102T2 (de) Methode fuer die behandlung von viraler gehirnentzuendung.
DE19512227C1 (de) Multifaktorielles Abwehr-Modulatorengemisch, Verfahren zu seiner Herstellung und diese Modulatoren enthaltende Arzneimittel
DE69013002T2 (de) Uv-induzierter faktor für immununterdrückung.
DE3235913C2 (de) Verfahren zur Gewinnung eines Krankheitskontrollprodukts

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee